SUPPLEMENT
SUSTAINABILITY PRESSURES, DIGITALISATION AND TALENT SHORTAGES IN PHARMA AIRFREIGHT
T
he pharmaceutical airfreight sector has become one of the most strategically important yet operationally complex components of global healthcare. Medicines, vaccines and advanced therapies must often move rapidly across borders in tightly controlled conditions, leaving air transport as the only viable mode. Yet three
converging forces are reshaping the sector: the intensifying drive towards sustainability, the accelerating adoption of digital technologies, and an acute shortage of skilled personnel. Each of these forces carries both risk and opportunity and together they define the commercial reality of 2025. The pharma airfreight industry is navigating a decisive period. Sustainability
pressures demand innovation in packaging and energy use, while digitalisation promises unprecedented visibility and efficiency. Yet the shortage of skilled personnel threatens to slow progress on both fronts. The sector’s ability to thrive will rest on integrating these priorities into a coherent strategy – one that treats environmental responsibility, technological capability and human capital not as separate challenges but as interconnected levers of competitiveness. Those that succeed will set the benchmark for a resilient, efficient and responsible supply chain in the years ahead. One area of change lies in packaging and containers. Traditional single-use
solutions are increasingly unacceptable due to their environmental footprint. In response, carriers are adopting reusable passive thermal containers, such as those produced by Envirotainer, which are capable of maintaining precise temperature ranges over long distances. Not only do these reduce waste, but they also lower total cost of ownership over repeated use. Similarly, DHL has launched its GoGreen Plus service, enabling
customers to book air cargo shipments with a verified reduction in carbon emissions by using sustainable aviation fuel (SAF). While more costly, such initiatives are becoming essential as pharmaceutical clients incorporate logistics emissions into their published ESG disclosures. A further example can be found at Heathrow and Frankfurt airports,
where operators are piloting solar-powered cold storage units. These facilities are designed to reduce reliance on grid electricity and serve as visible evidence of airports’ commitment to greener operations. For pharma firms, such infrastructure offers assurance that their sustainability targets can be met without jeopardising product integrity. These developments underline a broader reality: sustainability has
shifted from being a differentiator to becoming a condition of market entry. Logistics providers unable to credibly reduce their environmental impact risk being excluded from tenders by increasingly demanding pharma clients.
Acceleration of digitalisation If sustainability represents the external pressure, digitalisation is the internal transformation reshaping pharmaceutical airfreight. Clients now demand real-time visibility of their consignments, given that even minor temperature excursions can compromise the efficacy of high-value therapies. The sector is witnessing widespread deployment of IoT (Internet of
Things) sensor technology, which monitors not only temperature but also humidity, vibration and light exposure. Data is transmitted continuously to centralised control towers, enabling proactive intervention if deviations occur. For example, Kuehne + Nagel’s PharmaChain platform offers 24/7 visibility and predictive alerts, significantly reducing spoilage rates and providing reassurance to pharmaceutical manufacturers. Artificial intelligence is also being harnessed for predictive routing and
disruption management. UPS Healthcare, for instance, employs machine learning models to anticipate potential delays caused by weather or congestion and dynamically reroute shipments to minimise risk. Such systems deliver not only operational efficiency but also direct financial benefit, as fewer consignments are lost or written off. Blockchain technology is another avenue of innovation. Emirates
SkyCargo has piloted blockchain-enabled documentation to create tamper-proof records of custody for temperature-sensitive shipments. This supports compliance with Good Distribution Practice (GDP) regulations and offers clients a transparent audit trail – a valuable differentiator in a tightly regulated market.
15 across
However, digitalisation is not without its challenges. Integration international
supply chains remains uneven, with smaller
freight forwarders struggling to match the investment levels of larger competitors. This creates a risk of fragmentation, where only a subset of providers can deliver the high levels of visibility now expected by pharmaceutical clients.
Talent shortages Both sustainability initiatives and digital technologies ultimately depend on people. Here the industry faces its most significant bottleneck: a shortage of skilled talent. For example, managing a control tower equipped with IoT sensors requires staff who can interpret complex data, identify anomalies, and take corrective action in real time. Yet such analytical skills are in short supply. Furthermore,
demands technicians
the adoption of sustainable packaging technologies trained
to operate and maintain advanced
refrigeration equipment. Ground handling agents must understand not only compliance requirements but also the intricacies of reusable container systems. Staff turnover at airport handling facilities, however, remains high, raising concerns over knowledge retention. The talent shortage extends to software development and AI system
design. DHL and other major integrators report difficulty recruiting data scientists and engineers capable of tailoring predictive algorithms for logistics applications. In some cases, these skills are being sourced from outside the traditional logistics sector, with companies partnering with technology firms to bridge capability gaps. For senior leaders, the lesson is clear. Sustainability, digitalisation and
talent cannot be treated as discrete priorities; they are interdependent. A provider investing in SAF-based airfreight must still ensure that its staff can accurately measure and report emissions reductions. A company deploying IoT monitoring must simultaneously train personnel capable of acting on the data. And without credible sustainability credentials, even the most advanced digital offering may fail to win pharmaceutical business. The future of pharma airfreight will therefore belong to those firms
that not only invest in technology and green infrastructure but also develop and retain the skilled workforce required to operate them. This means new recruitment strategies, industry-wide training initiatives, and stronger collaboration between logistics providers, companies and educational institutions.
“Clients now
demand real- time visibility of their
consignments, given that even minor temperature
excursions can compromise the efficacy
of high-value therapies.”
technology
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20